Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Annalise Enterprise

K-Number: K253818 · 2026-03-03

Decision Date2026-03-03
Product CodeQAS
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Annalise Enterprise is a medical device manufactured by Harrison-AI Medical Pty, Ltd.. It received FDA 510(k) clearance on 2026-03-03 under approval number K253818. The device is classified under product code QAS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Annalise Enterprise?

Annalise Enterprise is a medical device that received FDA 510(k) clearance on 2026-03-03. It is manufactured by Harrison-AI Medical Pty, Ltd.. The 510(k) number is K253818.

When was Annalise Enterprise approved by the FDA?

Annalise Enterprise received FDA 510(k) clearance on 2026-03-03, under approval number K253818.

What company makes Annalise Enterprise?

Annalise Enterprise is manufactured by Harrison-AI Medical Pty, Ltd..

What is the FDA product code for Annalise Enterprise?

The FDA product code for Annalise Enterprise is QAS.

Related Devices (Code: QAS)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.